The immune system’s pro-inflammatory environment in IBD, characterized by cytokine dysregulation (e.g., TNF-α, IL-6, IL-1β), may contribute to systemic inflammation, further exacerbating insulin resistance in older individuals. This evidence concerns the gene TNF and inflammatory bowel disease.